Return to Activity at Altitude After High-Altitude Illness

被引:6
|
作者
DeWeber, Kevin [1 ]
Scorza, Keith [2 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[2] DeWitt Army Community Hosp, Ft Belvoir, VA 22060 USA
来源
SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH | 2010年 / 2卷 / 04期
关键词
altitude illness; athlete; activity;
D O I
10.1177/1941738110373065
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
Context: Sports and other activities at high altitude are popular, yet they pose the unique risk for high-altitude illness (HAI). Once those who have suffered from a HAI recover, they commonly desire or need to perform the same activity at altitude in the immediate or distant future. Evidence Acquisition: As based on key text references and peer-reviewed journal articles from a Medline search, this article reviews the pathophysiology and general treatment principles of HAI. Results: In addition to the type of HAI experienced and the current level of recovery, factors needing consideration in the return-to-play plan include physical activity requirements, flexibility of the activity schedule, and available medical equipment and facilities. Most important, adherence to prudent acclimatization protocols and gradual ascent recommendations (when above 3000 m, no more than 600-m net elevation gain per day, and 1 rest day every 1 to 2 ascent days) is powerful in its preventive value and thus strongly recommended. When these are not practical, prophylactic medications (acetazolamide, dexamethasone, salmeterol, nifedipine, or phosphodiesterase inhibitors, depending on the type of prior HAI) may be prescribed and can reduce the risk of illness. Athletes with HAI should be counseled that physical and mental performance may be adversely affected if activity at altitude continues before recovery is complete and that there is a risk of progression to a more serious HAI. Conclusion: With a thoughtful plan, most recurrent HAI in athletes can be prevented.
引用
收藏
页码:291 / 300
页数:10
相关论文
共 50 条
  • [21] Isolated facial and hypoglossal nerve palsies at high altitude
    Basnyat, B
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2001, 2 (02) : 301 - 303
  • [22] Alveolar haemorrhage in a case of high altitude pulmonary oedema
    Grissom, CK
    Albertine, KH
    Elstad, MR
    THORAX, 2000, 55 (02) : 167 - 169
  • [23] SUCCESSFUL USE OF THE GAMOW-HYPERBARIC BAG IN THE TREATMENT OF ALTITUDE ILLNESS AT MOUNT EVEREST
    KING, SJ
    GREENLEE, RR
    JOURNAL OF WILDERNESS MEDICINE, 1990, 1 (03): : 193 - 202
  • [24] Reascent following resolution of high altitude pulmonary edema (HAPE)
    Litch, J
    Bishop, RA
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2001, 2 (01) : 53 - 55
  • [25] Preparticipation Screening with Medical Aspects of High Altitude and Scuba Diving
    Dehnert, Christoph
    AKTUELLE KARDIOLOGIE, 2020, 9 (02) : 146 - 152
  • [26] Physiological Effects of Sildenafil Versus Placebo at High Altitude: A Systematic Review
    Poudel, Sangeeta
    Gautam, Sandesh
    Adhikari, Purushottam
    Zafren, Ken
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2024, 25 (01) : 16 - 25
  • [27] Evaluating the Risks of High Altitude Travel in Chronic Liver Disease Patients
    Luks, Andrew M.
    Swenson, Erik R.
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2015, 16 (02) : 80 - 88
  • [28] Counseling Patients with Chronic Obstructive Pulmonary Disease Traveling to High Altitude
    Bloch, Konrad E.
    Sooronbaev, Talant M.
    Ulrich, Silvia
    Lichtblau, Mona
    Furian, Michael
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2023, 24 (03) : 158 - 166
  • [29] Impedance cardiography as a tool for haemodynamic monitoring at high altitude: a preliminary study
    Krzesinski, Pawel
    Sadlon, Narcyz Michal
    Grudzien, Kamil Tomasz
    Gielerak, Grzegorz
    Stanczyk, Adam
    KARDIOLOGIA POLSKA, 2012, 70 (09) : 911 - 917
  • [30] High altitude cerebral edema and acute mountain sickness - A pathophysiology update
    Hackett, PH
    HYPOXI: INTO THE NEXT MILLENNIUM, 1999, 474 : 23 - 45